K-Beauty Job Growth Surges as Biohealth Industry Workforce Exceeds 1.14 Million

The Korea Health Industry Development Institute announced on the 10th that the biohealth industry workforce has surpassed 1.14 million, marking a 3.6% increase (around 40,000 individuals) compared to the previous year. This signifies a sustained growth trajectory within the sector, driven largely by a notable expansion in the cosmetic sector, which has seen a remarkable 9.1% rise in employment, outperforming other manufacturing subsectors.

Utilizing data from the Employment Labor Data System (ELDS) and reflecting the revised 11th edition of the Korean Standard Industrial Classification (KSIC), this employment trend underscores the inclusive growth across various business sizes. Notably, large enterprises with over 300 employees recorded a 12.3% increase in their workforce, while smaller firms (those employing between 30 to 300 and under 30) expanded by 7.4%. This broad growth pattern highlights an increasingly synergistic landscape between large and small cosmetics firms, which could influence market positioning strategies.

In the pharmaceutical sector, the workforce totaled 86,000 employees, representing a modest 2.3% year-on-year increase. Particularly in the ‘Synthetic Pharmaceuticals and Other Finished Drug Manufacturing’ category, steady employment growth has been evident, with the increase rate rising from 1.4% in Q4 the previous year to 2.2% in Q1 this year. This shift points to a trend where larger pharmaceutical companies are scaling operations, boosting employment at a higher rate, which could have implications for suppliers and distribution partners.

Healthcare devices have seen a workforce of 65,000, with a 2.4% increase compared to the previous year. However, this growth has predominantly been driven by medium to large-scale enterprises, suggesting a potential pivot in industry dynamics as smaller businesses face workforce reductions. The healthcare services sector, emphasizing a substantial share of the biohealth employment, employed 946,000 individuals in Q1, representing a 3.6% increase—significantly outpacing overall service sector growth. This trend could attract further investments as healthcare is poised to become a cornerstone of economic stability in the region.

In total, 12,327 new jobs were created, with the healthcare service sector accounting for 10,518 positions (85.3%). Following the healthcare segment, the pharmaceutical sector contributed 792 jobs, the medical device sector 555 positions, and cosmetics accounted for 462 jobs. This job creation breakdown illustrates the sector’s capacity to absorb new talent, particularly among younger demographics, further indicating a strategic advantage in future workforce planning.

Choi Young-im, head of the Biohealth Innovation Planning Division, remarked, "The workforce in the biohealth industry continues its steady growth, particularly within large-scale operations. The cosmetics industry has notably increased job opportunities for younger workers, solidifying its role as the growth driver in biohealth manufacturing." As the industry adapts to the new KSIC classification, future data collection and analysis will provide clearer insights into sustained employment trends.

Industry experts attribute the growth of the K-beauty sector to favorable export conditions, the strengthening of technological capabilities in pharmaceuticals and medical devices, and burgeoning demand for healthcare services. The cosmetics industry stands out for its potential to create youth employment and is increasingly viewed as a key growth area within the biohealth sector, which is crucial for domestic job creation.